Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
Manage your formulary budget
Drug patents …
… from Kazakhstan to Kalamazoo
Proactively manage your pharmacy inventory
Anticipate generic drug launch
|Title:||Enterically coated cysteamine, cystamine and derivatives thereof|
|Abstract:||The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.|
|Inventor(s):||Dohil; Ranjan (San Diego, CA), Schneider; Jerry (La Jolla, CA)|
|Assignee:||The Regents of the University of California (Oakland, CA)|
Patent Claim Types:|
see list of patent claims
|Composition; Delivery; Formulation;|
Field: Basic materials chemistry
Back Citations: 12th percentile
Forward Citations: 5th percentile
|Patent Number||Expiration Date|
|8,129,433||March 06, 2016|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.